Funding · Company
Lonestar Medicines, Inc.
Boston, MABiotech & Pharma
Lonestar Medicines, Inc. of Boston, MA has disclosed $25M across 1 Form D offering filed with the SEC on Feb 23, 2026.
$25M
Total disclosed
1
Form D offering
2025
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$25M
Form D · Feb 23, 2026 ↗
Q1 2026
· target $45M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2025SEC CIK0002111460Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →